Trial intelligence / Profile preview

Hydroxychloroquine in HIV-infected HAART-treated immunological non-responders

2009-012499-28Phase 4Completed

Sponsor
Luigi Sacco University Hospital
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of hydroxychloroquine in human immunodeficiency virus infection (HIV), sponsored by Luigi Sacco University Hospital. Primary endpoint: Absolute CD4 T cells increase. Started Aug 2009; status: completed.

02

Drugs

hydroxychloroquine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2009-012499-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012499-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call